Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of controlled feeding trials

European Journal of Clinical Nutrition

Volumn 68, Issue 4, 2014, Pages 416-423

  Chiu, S ^a   Sievenpiper, J L ^b,c,d   De Souza, R J ^a,c,e   Cozma, A I ^a,c   Mirrahimi, A ^a,c   Carleton, A J ^a,c   Ha, V ^a,c   Di Buono, M ^a,f,g   Jenkins, A L ^a,c   Leiter, L A ^a,c,h   Wolever, T M S ^a,c,h   Don Wauchope, A C ^b,i   Beyene, J ^e,j,k   Kendall, C W C ^a,c,l   Jenkins, D J A ^a,c,h  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f HEART AND STROKE FOUNDATION OF CANADA   (Canada)

^g AMERICAN HEART ASSOCIATION   (United States)

^h ST MICHAEL'S HOSPITAL   (Canada)

ⁱ HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

^k HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^l UNIVERSITY OF SASKATCHEWAN   (Canada)

more..

Author keywords

Clinical trial; Meta analysis; Non alcoholic fatty liver disease; Sugars

Indexed keywords

ALANINE AMINOTRANSFERASE; FRUCTOSE;

ADIPOCYTE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CALORIC INTAKE; CONFIDENCE INTERVAL; ENERGY BALANCE; ENERGY METABOLISM; HISTOPATHOLOGY; HUMAN; LIPID ANALYSIS; LIPOGENESIS; NONALCOHOLIC FATTY LIVER; PROTEIN POLYMORPHISM; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TISSUE LEVEL; FACTUAL DATABASE; META ANALYSIS; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; OBSERVATIONAL STUDY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ALANINE TRANSAMINASE; DATABASES, FACTUAL; FRUCTOSE; HUMANS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBSERVATIONAL STUDY AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84897993613     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2014.8     Document Type: Review

References (44)

1. Bhatia LS, Curzen NP, Calder PC, Byrne CD. Non-Alcoholic fatty liver disease: A new and important cardiovascular risk factor? Eur Heart J 2012; 33: 1190-1200.
2. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: A global perspective. Semin Liver Dis 2008; 28: 339-350.
3. Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E et al. Non-Alcoholic fatty liver disease and mortality among US adults: Prospective cohort study. BMJ 2011; 343: D6891.
4. Lustig RH, Schmidt LA, Brindis CD. Public health: The toxic truth about sugar. Nature 2012; 482: 27-29.
5. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol 2010; 7: 251-264.
6. Mouzaki M, Allard JP. The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease. J Clin Gastroenterol 2012; 46: 457-467.
7. Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K. Fructose: A highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2010; 299: E685-E694.
8. Ackerman Z, Oron-Herman M, Grozovski M, Rosenthal T, Pappo O, Link G et al. Fructose-induced fatty liver disease: Hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension 2005; 45: 1012-1018.
9. Zhang L, Perdomo G, Kim DH, Qu S, Ringquist S, Trucco M et al. Proteomic analysis of fructose-induced fatty liver in hamsters. Metabolism 2008; 57: 1115-1124.
10. Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I. Fructose-induced steatosis in mice: Role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells. Lab Invest 2011; 91: 885-895.
11. Spruss A, Kanuri G, Stahl C, Bischoff SC, Bergheim I. Metformin protects against the development of fructose-induced steatosis in mice: Role of the intestinal barrier function. Lab Invest 2012; 92: 1020-1032.
12. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, Halpern Z et al. Long term nutritional intake and the risk for non-Alcoholic fatty liver disease (NAFLD): A population based study. J Hepatol 2007; 47: 711-717.
13. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM et al. Fructose consumption as a risk factor for non-Alcoholic fatty liver disease. J Hepatol. 2008; 48: 993-999.
14. Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 2009; 51: 918-924.
15. Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated march 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org, 2011.
16. Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-Analyses: The PRISMA statement. BMJ 2009; 339: B2535.
17. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001; 286: 944-953.
18. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-Analyses involving cross-over trials: Methodological issues. Int J Epidemiol 2002; 31: 140-149.
19. Ngo Sock ET, Le KA, Ith M, Kreis R, Boesch C, Tappy L. Effects of a short-Term overfeeding with fructose or glucose in healthy young males. Br J Nutr 2010; 103: 939-943.
20. Silbernagel G, Machann J, Unmuth S, Schick F, Stefan N, Häring HU et al. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: An exploratory trial. Br J Nutr 2011; 106: 79-86.
21. Aeberli I, Gerber PA, Hochuli M, Kohler S, Haile SR, Gouni-Berthold I et al. Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: A randomized controlled trial. Am J Clin Nutr 2011; 94: 479-485.
22. LêKA, Faeh D, Stettler R, Ith M, Kreis R, Vermathen P et al. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr 2006; 84: 1374-1379.
23. LêKA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr 2009; 89: 1760-1765.
24. Sobrecases H, LêKA, Bortolotti M, Schneiter P, Ith M, Kreis R et al. Effects of short-Term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men. Diabetes Metab 2010; 36: 244-246.
25. Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC et al. Consumption of fructose- not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gammaglutamyl transferase activity in overweight/obese humans. Nutr Metab 2012; 9: 68.
26. Johnston RD, Stephenson MC, Grossland H, Cordon SM, Palcidi E, Cox EF et al. No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. Gastroenterology 2013; 145: 1016-1025.e2.
27. Lustig RH. Fructose: Metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc. 2010; 110: 1307-1321.
28. Sievenpiper JL, De Souza RJ, Kendall CW, Jenkins DJ. Is fructose a story of mice but not men? J Am Diet Assoc 2011; 111: 219-220.
29. Sun SZ, Empie M. Fructose metabolism in humans-what isotopic tracer studies tell us. Nutr Metab (Lond) 2012; 9: 89.
30. Tappy L, LêKA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 2010; 90: 23-46.
31. Kechagias S, Ernersson A, Dahlqvist O, Lundberg P, Lindström T, Nystrom FH et al. Fast-food-based hyper-Alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut 2008; 57: 649-654.
32. Musso G, Cassader M, Rosina F, Gambino R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-Alcoholic fatty liver disease (NAFLD): A systematic review and meta-Analysis of randomized trials. Diabetologia 2012; 55: 885-904.
33. Sievenpiper JL, De Souza RJ, Mirrahimi A, Yu ME, Carleton AJ, Beyene J et al. Effect of fructose on body weight in controlled feeding trials: A systematic review and meta-Analysis. Ann Intern Med 2012; 156: 291-304.
34. Wang DD, Sievenpiper JL, De Souza RJ, Chiavaroli L, Ha V, Cozma AI et al. The effects of fructose intake on serum uric acid vary among controlled dietary trials. J Nutr 2012; 142: 916-923.
35. Livesey G, Taylor R. Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: Meta-Analyses and meta-regression models of intervention studies. Am J Clin Nutr 2008; 88: 1419-1437.
36. Sievenpiper JL, Carleton AJ, Chatha S, Jiang HY, De Souza RJ, Beyene J et al. Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: Systematic review and meta-Analysis of experimental trials in humans. Diabetes Care 2009; 32: 1930-1937.
37. Ha V, Sievenpiper JL, De Souza RJ, Chiavaroli L, Wang DD, Cozma AI et al. Effect of fructose on blood pressure: A systematic review and meta-Analysis of controlled feeding trials. Hypertension 2012; 59: 787-795.
38. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462-E468.
39. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ et al. Nonalcoholic steatohepatitis clinical research network. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51: 1961-1971.
40. Marriott BP, Cole N, Lee E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr 2009; 139: 1228S-1235S
41. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-Term weight gain in women and men. N Engl J Med 2011; 364: 2392-2404.
42. Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr 2012; 142: 1304-1313.
43. Jenkins DJ, Srichaikul K, Kendall CW, Sievenpiper JL, Abdulnour S, Mirrahimi A et al. The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes. Diabetologia 2011; 54: 271-279.
44. Madero M, Arriaga JC, Jalal D, Rivard C, McFann K, Peárez- Meández O et al. The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: A randomized controlled trial. Metabolism 2011; 60: 1551-1559.